Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,091 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
R-CHOP therapy alone in limited stage diffuse large B-cell lymphoma.
Tomita N, Takasaki H, Miyashita K, Fujisawa S, Ogusa E, Matsuura S, Kishimoto K, Numata A, Fujita A, Ohshima R, Kuwabara H, Hagihara M, Hashimoto C, Takemura S, Koharazawa H, Yamazaki E, Fujimaki K, Taguchi J, Sakai R, Ishigatsubo Y. Tomita N, et al. Among authors: sakai r. Br J Haematol. 2013 May;161(3):383-8. doi: 10.1111/bjh.12281. Epub 2013 Feb 25. Br J Haematol. 2013. PMID: 23432318 Free article.
Phase II study of CHOP-GR therapy for advanced-stage follicular lymphoma.
Tomita N, Kodama F, Oshima R, Hashimoto C, Koharazawa H, Takemura S, Yamazaki E, Fujimaki K, Sakai R, Fujita H, Fujisawa S, Kanamori H, Motomura S, Ishigatsubo Y. Tomita N, et al. Among authors: sakai r. Leuk Lymphoma. 2006 Jun;47(6):1041-7. doi: 10.1080/10428190500472784. Leuk Lymphoma. 2006. PMID: 16840195 Clinical Trial.
Upfront autologous stem cell transplantation for untreated high-risk diffuse large B-cell lymphoma in patients up to 60 years of age.
Takasaki H, Hashimoto C, Fujita A, Matsumoto K, Taguchi J, Kuwabara H, Yamazaki E, Koharazawa H, Fujita H, Fujisawa S, Ishii Y, Yamamoto W, Motomura S, Tomita N, Ishigatsubo Y, Sakai R. Takasaki H, et al. Among authors: sakai r. Clin Lymphoma Myeloma Leuk. 2013 Aug;13(4):404-9. doi: 10.1016/j.clml.2013.03.003. Epub 2013 Jun 10. Clin Lymphoma Myeloma Leuk. 2013. PMID: 23763919
Absolute monocyte count in follicular lymphoma patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
Watanabe R, Tomita N, Kishimoto K, Koyama S, Ogusa E, Ishii Y, Miyashita K, Matsuura S, Fujisawa S, Hattori Y, Takasaki H, Fujita A, Ohshima R, Kuwabara H, Hashimoto C, Fujimaki K, Sakai R, Ishigatsubo Y. Watanabe R, et al. Among authors: sakai r. Leuk Res. 2013 Oct;37(10):1208-12. doi: 10.1016/j.leukres.2013.07.015. Epub 2013 Aug 5. Leuk Res. 2013. PMID: 23927994
Standard R-CHOP therapy in follicular lymphoma and diffuse large B-cell lymphoma.
Tomita N, Takasaki H, Fujisawa S, Miyashita K, Ogusa E, Kishimoto K, Matsuura S, Sakai R, Koharazawa H, Yamamoto W, Fujimaki K, Fujita H, Ishii Y, Taguchi J, Kuwabara H, Motomura S, Ishigatsubo Y. Tomita N, et al. Among authors: sakai r. J Clin Exp Hematop. 2013;53(2):121-5. doi: 10.3960/jslrt.53.121. J Clin Exp Hematop. 2013. PMID: 23995108 Free article.
Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large B-cell lymphoma in the rituximab era.
Watanabe R, Tomita N, Itabashi M, Ishibashi D, Yamamoto E, Koyama S, Miyashita K, Takahashi H, Nakajima Y, Hattori Y, Motohashi K, Takasaki H, Ohshima R, Hashimoto C, Yamazaki E, Fujimaki K, Sakai R, Fujisawa S, Motomura S, Ishigatsubo Y. Watanabe R, et al. Among authors: sakai r. Eur J Haematol. 2014 Mar;92(3):204-10. doi: 10.1111/ejh.12221. Epub 2013 Nov 28. Eur J Haematol. 2014. PMID: 24283206
Biweekly THP-COP therapy for newly diagnosed peripheral T-cell lymphoma patients.
Tomita N, Kodama F, Tsuyama N, Sakata S, Takeuchi K, Ishibashi D, Koyama S, Ishii Y, Yamamoto W, Takasaki H, Hagihara M, Kuwabara H, Tanaka M, Hashimoto C, Yamazaki E, Koharazawa H, Fujimaki K, Sakai R, Fujisawa S, Ishigatsubo Y. Tomita N, et al. Among authors: sakai r. Hematol Oncol. 2015 Mar;33(1):9-14. doi: 10.1002/hon.2136. Epub 2014 Feb 11. Hematol Oncol. 2015. PMID: 24519501 Clinical Trial.
1,091 results